Working… Menu
Trial record 1 of 1 for:    MK3475-598
Previous Study | Return to List | Next Study

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-small Cell Lung Cancer (MK-3475-598/KEYNOTE-598)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03302234
Recruitment Status : Active, not recruiting
First Posted : October 5, 2017
Last Update Posted : December 29, 2020
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.